日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Luvometinib in patients with Langerhans cell histiocytosis, Erdheim-Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study

Luvometinib治疗朗格汉斯细胞组织细胞增生症、埃尔德海姆-切斯特病和其他组织细胞肿瘤患者:一项单臂、多中心、II期研究

Cao, Xin-Xin; Zhu, Qi; Cai, Zhen; Ma, Jie; Zhou, Hui; Chang, Long; Zhong, Lai-Ping; Wu, Zhu-Li; Wang, Xingli; Han, Pu; Lin, Hong-Mei; Wei, Zhen; Guo, Jia-Yan; Zheng, Yang; Li, Jian

Bactericidal and sterilizing activity of sudapyridine-clofazimine-TB47 combined with linezolid or pyrazinamide in a murine model of tuberculosis

舒达吡啶-氯法齐明-TB47与利奈唑胺或吡嗪酰胺联合对小鼠结核病模型的杀菌和灭菌作用

Wei Yu #, Yanan Ju #, Xingli Han, Xirong Tian, Jie Ding, Shuai Wang, H M Adnan Hameed, Yamin Gao, Lei Li, Yongguo Li, Nanshan Zhong, Tianyu Zhang

Multimodal Treatment Combining Salvage Surgery-Assisted Chemotherapy and Checkpoints Blockade Immunotherapy Achieves Complete Remission on a Recurrent Penile Cancer Patient: A Case Report

挽救性手术辅助化疗联合免疫检查点阻断疗法的多模式治疗使复发性阴茎癌患者达到完全缓解:病例报告

Hu, Linjun; Shan, Xingli; Han, Dongdong; Guo, Zhaoxia; Wang, Huina; Xiao, Zejun